Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sector: Healthcare; Industry: Biotechnology

Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 12 years of age or older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator, or CFTR, gene. The company was founded in 1989 and is headquartered in Boston, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-05-03 Sanna Bastiano EVP, Cell & Genetic Therapies Sell 960 $218.43 $209,691 No
2021-04-27 Sachdev Amit EVP, Chief Patient Officer Sell 3,884 $216.06 $839,193 Yes
2021-04-05 Sanna Bastiano EVP, Cell & Genetic Therapies Sell 1,686 $214.14 $361,046 No
2021-03-05 Liu Joy SVP, General Counsel Sell 5,141 $209.69 $1,078,018 No
2021-03-01 Silva Paul M SVP & Chief Accounting Officer Sell 2,782 $211.45 $588,255 No
2021-02-25 Silva Paul M SVP & Chief Accounting Officer Sell 1,080 $213.47 $230,552 No
2021-02-25 Sachdev Amit EVP, Chief Patient Officer Sell 3,586 $213.42 $765,307 No
2021-02-25 Parini Michael EVP, Chief Adm, Leg & BD Off Sell 3,028 $213.38 $646,125 No
2021-02-25 Arbuckle Stuart A EVP, Chief Commercial Officer Sell 3,634 $213.54 $775,989 No
2021-02-25 ALTSHULER DAVID EVP, Global Research and CSO Sell 3,028 $213.39 $646,139 No
2021-02-18 Silva Paul M SVP & Chief Accounting Officer Sell 4,295 $211.83 $909,828 No
2021-02-18 Sachdev Amit EVP, Chief Patient Officer Sell 9,264 $211.83 $1,962,366 No
2021-02-18 Parini Michael EVP, Chief Adm, Leg & BD Off Sell 7,825 $211.83 $1,657,556 No
2021-02-18 Arbuckle Stuart A EVP, Chief Commercial Officer Sell 7,825 $211.82 $1,657,481 No
2021-02-18 ALTSHULER DAVID EVP, Global Research and CSO Sell 7,825 $211.83 $1,657,590 No
2021-02-11 Silva Paul M SVP & Chief Accounting Officer Sell 1,498 $210.57 $315,437 No
2021-02-11 Sanna Bastiano EVP, Cell & Genetic Therapies Sell 1,686 $210.56 $355,012 No
2021-02-11 Sachdev Amit EVP, Chief Patient Officer Sell 4,460 $210.55 $939,068 No
2021-02-11 Parini Michael EVP, Chief Adm, Leg & BD Off Sell 4,318 $210.56 $909,179 No
2021-02-11 Arbuckle Stuart A EVP, Chief Commercial Officer Sell 5,156 $210.55 $1,085,593 No
2021-02-11 ALTSHULER DAVID EVP, Global Research and CSO Sell 5,283 $210.54 $1,112,274 No
2021-02-05 Parini Michael EVP, Chief Adm, Leg & BD Off Sell 1,930 $215.00 $414,950 Yes
2021-02-03 Parini Michael EVP, Chief Adm, Leg & BD Off Sell 400 $216.56 $86,624 Yes
2021-02-03 Arbuckle Stuart A EVP, Chief Commercial Officer Sell 1,554 $213.74 $332,146 Yes
2020-11-16 Sachdev Amit EVP, Chief Patient Officer Sell 42 $223.53 $9,388 No
2020-11-16 Parini Michael EVP, Chief Adm, Leg & BD Off Sell 91 $223.53 $20,341 No
2020-11-16 Arbuckle Stuart A EVP, Chief Commercial Officer Sell 7 $223.64 $1,565 No
2020-11-16 ALTSHULER DAVID EVP, Global Research and CSO Sell 38 $223.47 $8,492 No
2020-11-10 SACHS BRUCE I Director Buy 15,000 $217.36 $3,260,465 No
2020-11-04 Parini Michael EVP, Chief Adm, Leg & BD Off Sell 2,330 $217.74 $507,329 Yes

Insider Smart

Liberty Media Corp (LSXMA) - BERKSHIRE HATHAWAY INC, Buffett made a move and add 2M shares to their position. What a news after dumping Airlines.

Insider Smart

Ovintiv Inc (OVV) - Insiders of OVV have been HEAVILY accumulating shares in March with a sub-$3 cost. And the stock is now $11. An awesome 400% gain can't be missed if you found it was heavily accumulated earlier.